This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pearse, R. N. Search for Related Content PubMed PubMed Citation Articles by Pearse, R. N.

Wnt Antagonism in Multiple Myeloma: A Potential Cause of Uncoupled Bone Remodeling

Author's Affiliation: Division of Hematology/Oncology, Cornell University Medical College, New York, New York

Requests for reprints: Roger N. Pearse, Division of Hematology/Oncology, Cornell University Medical College, 1300 York Avenue, Box 113, New York, NY 10021. Phone: 212-746-3964; Fax: 212-746-7888; E-mail: rnp2001{at}med.cornell.edu.

Bone disease in patients with multiple myeloma (MM) is characterized by uncoupled bone remodeling, evident as enhanced osteolytic resorption and decreased rather than increased bone formation. MM-triggered osteolysis follows deregulation of the receptor activator of nuclear factor B ligand (RANKL)/osteoprotegerin cytokine axis. Inhibition of bone formation may result from the ability of MM to inhibit the function of Wnts, secreted glycoproteins critical to osteoblast development. Recent studies show how these processes may be linked.

This article has been cited by other articles:

				C.-S. Chim, C. P. Bik Yiu, and W. H. Shek Pathological Bone Fracture in Non-Hodgkin's Lymphoma J. Clin. Oncol., July 20, 2007; 25(21): 3175 - 3176. [Full Text] [PDF]